Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene for keratosis pilaris
TCTR20261029004Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of trifarotene in keratosis pilaris (KP) (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Primary efficacy endpoint. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
trifarotene
03
Conditions
keratosis pilaris (KP)
Beyond the preview
Go deeper on TCTR20261029004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261029004.